Whittier Trust’s Astera Labs ALAB Stock Holding History

Whittier Trust’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$118K	Hold	273	–	–	﹤0.01%	712
2026 Q1	$32.2K	Hold	273	–	–	﹤0.01%	911
2025 Q4	$44K	Hold	273	–	–	﹤0.01%	892
2025 Q3	$54.8K	Buy	+273	New	+$44.9K	﹤0.01%	833

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Whittier Trust's ALAB Position: Q2 2026 in Review

Whittier Trust held its Astera Labs (ALAB) position steady in Q2 2026 at 273 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #712.

Whittier Trust first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Whittier Trust held 273 shares of Astera Labs worth $118K as of Q2 2026.
Whittier Trust left its Astera Labs share count unchanged in Q2 2026.
Astera Labs made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #712 holding.
Whittier Trust first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.